Cancer chemotherapy received in the past 4W or will be received in the next 4W

General Details:

Name:
Cancer chemotherapy received in the past 4W or will be received in the next 4W
Steward:
LOINC
Registration Status:
Qualified

Permissible Values:

Data Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
1 Yes LA33-6 LOINC
2 No LA32-8 LOINC
7 Refused LA4389-8 LOINC
9 Don't know LA12688-0 LOINC

Designations:

Designation:
Cancer chemotherapy received in the past 4W or will be received in the next 4W
Tags:
Long Common Name
Designation:
Chemotherapy rcvd past 4W or next 4W
Tags:
Short Name
Designation:
Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Tags:
Question Text

Properties:

Key:
Related Names
Value:
CancerChemoChemotherapy rcvd past 4W
Chemotherapy rcvd past 4W or next 4WFindingFindings
LastONCOLOGYOrdinal
Point in timeQLQual
QualitativeRandomScreen
Key:
Related Codes
Value:
Code SystemCodeCode TextCode Version
https://www.phenxtoolkit.orgPX811301020000PX811301_SerumPlasmaFerritin_Chemotheraphy_4weekshttps://www.phenxtoolkit.orgPX230201020000PX230201_Adipocytokines_Chemotherapyhttps://www.phenxtoolkit.orgPX250701020000PX250701_Cystatin_C_Assay_Kidney_Function_Chemotherapy
https://www.phenxtoolkit.orgPX810801020000PX810801_Haptoglobin_Chemotheraphy_4weekshttps://www.phenxtoolkit.orgPX810901020000PX810901_Billirubin_Chemotheraphy_4weekshttps://www.phenxtoolkit.orgPX811001020000PX811001_Lactate_Dehydrogenase_Chemotheraphy_4weeks
https://www.phenxtoolkit.orgPX811201020000PX811201_Aspartate_Aminotransferase_Chemotheraphy_4weekshttps://www.phenxtoolkit.orgPX140801070000PX140801_Chemotherapyhttps://www.phenxtoolkit.orgPX140802070000PX140802_Chemotherapy
https://www.phenxtoolkit.orgPX140901020000PX140901_Chemotherapyhttps://www.phenxtoolkit.orgPX141001070000PX141001_Chemotherapyhttps://www.phenxtoolkit.orgPX141201040000PX141201_Chemotherapy
https://www.phenxtoolkit.orgPX141301040000PX141301_Chemotherapyhttps://www.phenxtoolkit.orgPX141401020000PX141401_Chemotherapyhttps://www.phenxtoolkit.orgPX160201020000PX160201_Chemotherapy
https://www.phenxtoolkit.orgPX160301020000PX160301_Chemotherapyhttps://www.phenxtoolkit.orgPX160401020000PX160401_Chemotherapyhttps://www.phenxtoolkit.orgPX160501020000PX160501_Chemotherapy
https://www.phenxtoolkit.orgPX160701020000PX160701_Chemotherapyhttps://www.phenxtoolkit.orgPX160901020000PX160901_Chemotherapyhttps://www.phenxtoolkit.orgPX170101020000PX170101_Chemotherapy
https://www.phenxtoolkit.orgPX190301020000PX190301_Chemotherapyhttps://www.phenxtoolkit.orgPX190801020000PX190801_Chemotherapyhttps://www.phenxtoolkit.orgPX220501020000PX220501_CompleteBloodCount _Chemotherapy_4weeks
Key:
Fully-Specified Name
Value:
ComponentPropertyTimeSystemScaleMethod
Cancer chemotherapy received in the past 4W or will be received in the next 4WFindPt^PatientOrd
Key:
Basic Attributes
Value:
ClassTypeFirst ReleasedLast UpdatedChange Reason
ONCOLOGYClinicalVersion 2.36Version 2.68Release 2.68: COMPONENT: Updated Component name to represent the clinical concept rather than the specific question from the original source since the question asked will vary across forms and assessments.; CLASS: Moved term to the more representative Class for this concept.; METHOD_TYP: Removed Method of "PhenX" since this is a general concept not specific to PhenX and can be applied to various use cases.; Previous Releases: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.
Key:
Third Party Copyright
Value:
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO. This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov. Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
Key:
LOINC Copyright
Value:
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO. This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov. Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

Identifiers:

Source:
NLM
Id:
myra8qj2ix
Version:
1.1
Source:
LOINC
Id:
66178-5
Version:
2.69